Nucleic Acid Probes for Plasmodium Species Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing malaria, particularly in resource-limited settings, face challenges in accurately and rapidly detecting and differentiating between Plasmodium species due to limitations in sensitivity and specificity, especially at low parasitemia levels, and require advanced laboratory equipment or expertise.
Innovation Solution
Development of nucleic acid probes that can discriminate between P. falciparum, P. vivax, P. malariae, and P. ovale in hybridization assays, with low cross-reactivity, using specific sequences for hybridization and detection in biological samples.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If polymerase chain reaction is used to detect parasite nucleic acids, then detection accuracy is improved, but cost and equipment requirements increase
Solution Approach 1:
The patent employs disposable nucleic acid probes that can be used in simple hybridization assays. These probes are designed to be single-use or limited-use reagents that do not require complex instrumentation, thereby achieving accurate detection while avoiding the need for expensive, specialized laboratory equipment like PCR machines.
Solution Approach 2:
The patent replaces the complex mechanical and thermal cycling system of PCR with a simpler hybridization-based detection system. By using nucleic acid probes that hybridize to target sequences under controlled conditions, the invention substitutes the elaborate PCR apparatus with a more accessible method that maintains detection accuracy without requiring specialized equipment.
2Measurement precision
If thick film microscopy is used to screen larger volume of blood, then sensitivity is improved, but species identification capability deteriorates
Solution Approach 1:
The patent introduces nucleic acid probes as an intermediary that bridges the gap between sensitivity and identification. The probes hybridize to species-specific sequences in the parasite nucleic acids extracted from the blood sample, thereby providing both sensitive detection (by amplifying the signal from low parasite loads) and accurate species identification (through sequence-specific binding), without requiring the parasite morphology to be preserved.
3Reliability
If nucleic acid probes are used for species discrimination, then cross-reactivity is reduced, but assay complexity increases
Solution Approach 1:
The patent divides the detection task into separate, specific probe-target interactions. Each nucleic acid probe is designed to recognize a unique sequence in a specific Plasmodium species, segmenting the overall detection process into independent, specific binding events. This segmentation reduces cross-reactivity because each probe only binds to its intended target, while the assay remains relatively simple as it relies on straightforward hybridization and detection steps.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid, accurate detection and differentiation of malaria-causing Plasmodium species with minimal cross-reactivity, facilitating early diagnosis and treatment in field settings without the need for specialized laboratories.
Implementation Method 1
contacting the sample with a nucleic acid probe under conditions that permit hybridization; detecting the probe bound to the Plasmodium nucleic acid
Data Source
AI summary
This invention relates to novel nucleic acid-based probes and methods for detecting Plasmodium parasites in biological samples as well as detecting different Plasmodium parasites selectively from one another.